This stock is in Healthcare: revenue rank 88 of 540, share 0.1%.
88 / 5400.1%revenue share
$145.51+0.90%
2026-10-06 closeNeurocrine Biosciences's close-price date is 2026-10-06. Trailing 12 months PER is 21.5×. Latest quarter PBR is 4.10×. The comparison sector is Healthcare.
Sector grades
A-
Overall: Healthcare 195/740 · top 26%
Factor composite · relative position in sector
Industry structure
USAs of 2026-10-07Healthcare
Who dominates this industry?
- 1CVS Health14.1%
- 2McKesson13.6%
- 3Cigna9.4%
- 4Cardinal Health8.4%
- 5Centene6.2%
- 6Neurocrine Biosciences0.1%
Concentration
DistributedCR3 37.1%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
Winner-take-all deepeningConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 165.83
- Direction
- 확대
- Level
- 넓음
- Years
- 21
Value lens
- P90/P10
- 23.3
- Median P/B
- 3.02
- Level
- 넓음
- n
- 459
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Valuation bands — last annual report
The four key numbers use trailing earnings and the latest quarterly book value when available. These bands use the last annual report, so the values can differ.
PER 42.51 · PBR 5.6 — own-history percentile 89/100 · 67/100
Open self-history band
PER89/100
PBR67/100
Factual information · not investment advice
Quantus Signal · live data · not investment advice · Privacy Policy